top of page

Our Mission

 accelerate immune therapies R&D by automating precise analysis of T-cell responses

Unmatched Efficiency for Immune Therapy Developers

100XBIO is a biotech automation startup based in Boston, Massachusetts, founded in 2023.

Our technology can automate some of the most complex immunological cell-based assays.

 

Our solutions are designed for researchers and team leaders in academia and biotech industry focused on developing cutting-edge immune therapies.

Our Team

We have a team of partners and advisors to cover your immunology automation needs.

Screenshot_2024-08-01_at_3.29_edited.png

Sergei Pustylnikov, Ph.D. 

Founder & CEO

1680819033747_edited.png

ML Engineer

Core Team

Get in Touch

100XBIO @C2I Accelerator

299 Washington St

Woburn, MA 01801 

  • LinkedIn
  • X
  • YouTube
bottom of page